ArticleBMC cancer2026

Five-year prognostic impact of pre-existing interstitial lung disease in non-small cell lung cancer patients treated with anti-PD-1 monotherapy: a retrospective analysis.

Teppei Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.